Ocular Therapeutix: Fourth Quarter Earnings Overview

Ocular Therapeutix Reports Fourth Quarter Financial Results

Ocular Therapeutix Inc., headquartered in Bedford, Massachusetts, announced a net loss of $64.7 million for the fourth quarter.

The company reported a per-share loss of 29 cents during this period.

Despite the loss, the results were better than anticipated by Wall Street analysts, who had predicted a loss of 33 cents per share according to a survey by Zacks Investment Research.

Quarterly revenue reached $13.3 million, which fell short of the $15.1 million forecasted by four analysts polled by Zacks.

For the full year, Ocular Therapeutix recorded a total loss of $265.9 million, or $1.42 per share, with annual revenue totaling $52 million.